Home Companies AzurRx BioPharma Inc. (NASDAQ: AZRX) stock plunges in the current market trading....

AzurRx BioPharma Inc. (NASDAQ: AZRX) stock plunges in the current market trading. What is happening?

AzurRx BioPharma Inc. (NASDAQ: AZRX) stock falls by 8.93% at last check during the current market trading. Related to this decline in AZRX stock price, there is no recent news available. AzurRx BioPharma is a biopharmaceutical clinical-stage organization that specializes in developing targeted, non-systemic treatments for gastrointestinal diseases. AZRX has a three-good GI resource pipeline. The primary diagnostic candidate in patients with cystic fibrosis and chronic pancreatitis is MS1819 which is a recombinant lipase for the cure of exocrine pancreatic insufficiency.

Recent Past Development

On 15 April 2021, James Sapirstein, CEO and Chairman, sent a letter to its shareholders outlining the accomplishments of AZRX in the first and last quarter of 2021 and recent weeks. In his letter, he mentioned that AzurRx kicked off 2021 with the announcement of a game-changing in-licensing agreement with First Wave Bio, which introduced a new asset, patented formulations of micronized niclosamide, to its clinical-stage pipeline, along with 2 additional therapeutic indications for COVID-19 GI infections and immune checkpoint inhibitor-associated colitis (ICI-AC).


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


He went on to say that he is pleased to announce that both niclosamide programs are on pace to begin in the clinic. AZRX announced the launch of RESERVOIR, a Phase 2 (Proof of Principle) clinical trial of niclosamide for the cure of COVID-19-related gastrointestinal infections, in April 2021, and they enlisted PPD, Inc., a leading clinical research organization (CRO), to handle the Phase 1b/2a ICI-AC trial, which they expect to start in Q2 2021.

AZRX has continued to improve MS1819 as a possible therapy for exocrine pancreatic insufficiency (EPI) in cystic fibrosis patients (CF). AZRX announced topline results from its Phase 2b OPTION 2 monotherapy test at the end of Q1 2021 and expects to announce topline data from its Phase 2 combination therapy trial combining MS1819 with the existing standard of treatment, pancreatic enzyme replacement therapy (PERT), in Q2 2021. MS1819 also has the ability to replace PERT as the gold standard treatment for EPI in patients with CF and chronic pancreatitis, according to AZRX.

Whereas,

These are just the beginning of the tale. AzurRx remains committed to its goal of developing valuable GI therapies with substantial market potential and generating value for its shareholders.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Oragenics Inc. (OGEN) stock gained during current market. What’s driving it high?

Oragenics Inc. (OGEN) stock gains by 54.33% during the current market trading session. Oragenics, is a research and development firm focused on combating infectious...

Flora Growth Corp. (FLGC) stock declines during premarket. Here’s what you should know?

Flora Growth Corp. (NASDAQ: FLGC) stock gained by 49.67% at last close whereas the FLGC stock price plunged by 18.36% in the pre-market trading...

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

Smith Micro Develops Inc. (SMSI) stock soars during current market trading. Here’s to know why?

Smith Micro Develops Inc. (NASDAQ: SMSI) stock surged by 2.39% during the current market trading session. Smith Micro creates software that simplifies and improves...

Drive Shack Inc. (DS) stock soars during after-hour trading, followed by no recent update

Drive Shack Inc. (NASDAQ: DS) stock declined by 3.94% at last close while the DS stock-price surged by 7.38% in the after-hour session. Drive...

Oragenics Inc. (OGEN) stock gained during current market. What’s driving it high?

Oragenics Inc. (OGEN) stock gains by 54.33% during the current market trading session. Oragenics, is a research and development firm focused on combating infectious...

Tonix Pharmaceutics Holdings Inc. (TNXP) stock gains during current market. What’s driving it high?

Tonix Pharmaceuticals Holdings Inc. (TNXP) stock gains by 2.81% in the current market trading session. Tonix is a clinical-stage biopharmaceutical business dedicated on finding,...

Intec Pharma Inc. (NTEC) stock declines during current market after a massive upraise. What’s happening?

Intec Pharma Inc. (NASDAQ: NTEC) stock drops by 7.88% during the current market trading session. Intec Pharma is a clinical-stage biopharmaceutical firm specializing in...

Related News

Lumentum Holdings Inc. (LITE) Stock Drops Despite Promising Fiscal Q3 2021 Financial Reports

Lumentum Holdings Inc. (LITE) stock prices were down by a significant 16.42% shortly after market trading commenced, bringing the price per share down to...

Lucira Health Inc. (NASDAQ:LHDX) stock rallied today in the current trading session; here’s why

In the current trading session at last check, Lucira Health Inc. (LHDX) shares had surged by 15.32% to the price of $5.87. LHDX's stock...

Comstock Mining Inc. (NASDAQ:LODE) stock plunged in the current trading session; here’s why

In the current trading session at the last check, Comstock Mining Inc. (LODE) stock had plunged -3.25% to trade at $3.21. LODE stock previously...

Greenpro Capital Corp. (GRNQ) Stock Price Is Rising Immensely, Here is What You Need to Know

Greenpro Capital Corp. (NASDAQ: GRNQ) a leading company primarily focused on the provision of cloud system resolution, financial consulting services, and corporate accounting services,...

Tilray Inc. (NASDAQ: TLRY) stock rises during current market trading. What is driving it high?

Tilray Inc. (NASDAQ: TLRY) stock gains by 17.17% in the current market trading. Tilray is a world leader in cannabis and cannabinoid research, cultivation,...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam